Lynch Ryan

Insider profile

Lynch Ryan's trades of Crescent Biopharma Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-06-23 2026-06-22 PlS Planned sale
34,264 +28.3%
123.85
US$2,270,395
34,264 +28.3% 123.85 US$2,270,395